Anti–IL-6 Receptor Antibody Suppresses Visual Dysfunction in AQP4 Peptide-Immunized Mice
Translational Vision Science & Technology · 2026
DOI: 10.1167/tvst.15.2.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2026. Verfasst von Yoshichika Katsura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Product Research Department, Chugai Pharmaceutical Co., Ltd, Kanagawa, Japan. Hauptthemen laut MEDLINE: Aquaporin 4, Receptors, Interleukin-6, Vision Disorders. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Product Research Department, Chugai Pharmaceutical Co., Ltd, Kanagawa, Japan.
- Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan.
Zitieren
APA
Katsura, Y., Nakatake-Furuie, Y., Onishi, S., Kato, C., Miyake, S., Serizawa, K., & Nakamura, M. (2026). Anti–IL-6 Receptor Antibody Suppresses Visual Dysfunction in AQP4 Peptide-Immunized Mice. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.15.2.6
Vancouver
Katsura Y, Nakatake-Furuie Y, Onishi S, Kato C, Miyake S, Serizawa K, et al. Anti–IL-6 Receptor Antibody Suppresses Visual Dysfunction in AQP4 Peptide-Immunized Mice. Translational Vision Science & Technology. 2026. doi:10.1167/tvst.15.2.6
BibTeX
@article{Katsura2026,
author = {Katsura, Yoshichika and Nakatake-Furuie, Yuko and Onishi, Shinichi and Kato, Chie and Miyake, Shota and Serizawa, Kenichi and Nakamura, Makoto},
title = {Anti–IL-6 Receptor Antibody Suppresses Visual Dysfunction in AQP4 Peptide-Immunized Mice},
journal = {Translational Vision Science & Technology},
year = {2026},
doi = {10.1167/tvst.15.2.6}
}
EUVIMED